Oncology Drugs Market Global Briefing 2018

Starting Price : $ 1000.00 $ 670.00 | Pages : 38 | Published : January 2018 | SKU CODE : 2778 | Format :

Oncology deals with diagnosis, prevention and treatment of cancer diseases. Anti-cancer or anti-neoplastic agents are the drugs that prevent or inhibit or halt the proliferation and maturation of neoplasms, an abnormal growth of tissues commonly referred as tumors. These drugs prevent the growth of malignant tumors by affecting the process of cell division or by damaging the DNA and initiate apoptosis or by preventing the development and spread of neoplastic cells. Several types of cancers that can be treated by oncology drugs are blood cancer, lung cancer, endocrine cancer, bone cancer, gastric cancer, colorectal cancer, skin cancer, breast cancer, pancreatic cancer, prostate cancers, ovarian cancer, ocular cancer and others.

The top five companies covered are F. Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences, Inc., Bayer AG and Takeda Pharmaceuticals. F. Hoffmann-La Roche Ltd. was the largest company in the oncology drugs market.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

Oncology Drugs Global Market Size

The global oncology drugs market was valued around $126 billion in 2017. North America was the largest region in the oncology drugs market in 2017, accounting for around 30% of the total market. The USA was the largest country in the market accounting for around 25% of the total market.

Oncology Drugs Global Market Trend

Companies in the oncology drug market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive oncology drug market, companies are developing innovative products as well as sharing skills and expertise with other companies.

Oncology Drugs Global Market Segmentation

The oncology drugs market in this report is segmented into oncology drugs, drugs for blood cancer, breast cancer, cervical cancer, lung cancer, prostate cancer, kidney cancer, colorectal cancer, thyroid cancer, non-small cell lung cancer, gastric cancer, brain tumor, pancreatic cancer, skin cancer, ovarian cancer, bladder cancer and others.
Blood cancer share attributes to large population of cancer patients suffering from various types of blood cancers such as Leukemia, Lymphoma, and Myeloma.
Breast cancer increases in aging population, improvement in the survival rates with early diagnosis, access to medical care and progressive improvement in treatment strategies contribute to the market share.
Cervical cancer contributing to the size of this market include increase in aging population, improved diagnosis for cervical cancer leading to more patients being exposed to treatment.
Lung cancer increases the demand for therapeutics which has contributed to the size of this market.

Mergers And Acquisitions In The Veterinary Healthcare Market
Shared Medical Appointments: Balancing Efficiency With Patient Satisfaction
Need A Doctor’s Appointment? Radiology Information System Is At Your Service!
Automation In Air Purification Manufacturing Sector
Wearable Technologies To Shorten The Distance Between Doctor And Patient
Next-gen Biologics- The Way Forward
The Telemedicine Technology Market Will More Than Double by 2022
Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion
Blood Glucose Test Strips Global Market Report 2018
View Report
Veterinary Services Global Market Report 2018
View Report
Podiatry Services Global Market Strategies and Opportunities to 2021
View Report
Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021
View Report
Biologics Global Market Opportunities And Strategies To 2021
View Report
Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021
View Report
Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021
View Report
Veterinary Services Global Market Opportunities And Strategies To 2021
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)